15 insiders reported 68 Form 4 transactions for IRONWOOD PHARMACEUTICALS INC (IRWD) over the past 18 months (most recent 2026-06-17). Recent activity: Currie Mark G (Director) Buy 63,481 shares, Duane Jon R (Director) Buy 63,481 shares, McHugh Julie (Director) Buy 63,481 shares, Shepard Jay (Director) Buy 63,481 shares, Kessler Marla L (Director) Buy 63,481 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | Currie Mark G | Director | Buy | 63,481 | $0 |
| 2026-06-17 | Duane Jon R | Director | Buy | 63,481 | $0 |
| 2026-06-17 | McHugh Julie | Director | Buy | 63,481 | $0 |
| 2026-06-17 | Shepard Jay | Director | Buy | 63,481 | $0 |
| 2026-06-17 | Kessler Marla L | Director | Buy | 63,481 | $0 |
| 2026-06-17 | DENNER ALEXANDER J | Director | Buy | 4,065 | $0 |
| 2026-06-17 | Moukheibir Catherine | Director | Buy | 63,481 | $0 |
| 2026-06-17 | DENNER ALEXANDER J | Director | Buy | 63,481 | $0 |
| 2026-06-17 | McHugh Julie | Director | Sell | 21,571 | $80,460 |
| 2026-05-21 | Silver Ronald | PFO & PAO | Buy | 25,000 | $0 |
| 2026-03-17 | DENNER ALEXANDER J | Director | Sell | 5,800 | $19,198 |
| 2026-03-17 | DENNER ALEXANDER J | Director | Sell | 6.7M | $20.5M |
| 2026-03-17 | DENNER ALEXANDER J | Director | Buy | 4,451 | $0 |
| 2026-03-12 | Gaskins Tammi L | Chief Commercial Officer | Buy | 136,612 | $0 |
| 2026-03-12 | MCCOURT Thomas A | Chief Executive Officer | Buy | 409,836 | $0 |
| 2026-03-12 | Martini Gregory S. | Chief Financial Officer | Buy | 136,612 | $0 |
| 2026-03-12 | John Minardo | Chief Legal Officer | Buy | 136,612 | $0 |
| 2026-03-12 | Silver Ronald | Principal Accounting Officer | Buy | 163,934 | $0 |
| 2026-03-12 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Buy | 136,612 | $0 |
| 2026-02-25 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Sell | 15,570 | $59,322 |
| 2026-02-25 | Gaskins Tammi L | Chief Commercial Officer | Sell | 11,239 | $41,135 |
| 2026-02-25 | MCCOURT Thomas A | Chief Executive Officer | Sell | 94,757 | $361,024 |
| 2026-02-25 | MCCOURT Thomas A | Chief Executive Officer | Sell | 103,526 | $378,905 |
| 2026-02-25 | Gaskins Tammi L | Chief Commercial Officer | Sell | 10,287 | $39,193 |
| 2026-02-25 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Buy | 17,012 | $62,264 |
Source: SEC Form 4 filings · as of 2026-06-17